References
- Ciccone A., Valvassori L., Gasparotti R., Scomazzoni F., Ballabio E., Sterzi R. Debunking 7 myths that hamper the realization of randomized controlled trials on intra-arterial thrombolysis for acute ischemic stroke. Stroke 2007; 38: 2191–5
- Shaltoni H. M., Albright K. C., Gonzales N. R., Weir R. U., Khaja A. M., Sugg R. M., et al. Is intra-arterial thrombolysis safe after full dose intravenous recombinant tissue plasminogen activator for ischemic stroke?. Stroke 2007; 38: 80–4
- Furlan A., Higashida R., Wechler L., Gent M., Rowley H., Kase C., et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999; 282: 2003–11
- Kim D. J., Kim D. I., Byun J. S., Jung J. Y., Suh S. H., Kim E. Y., et al. Simple microwire and microcatheter mechanical thrombolysis with adjuvant intraarterial urokinase for treatment of hyperacute ischemic stroke patients. Acta Radiol 2008; 49: 351–357
- Labiche L. A., Al-Senani F., Wojner A. W., Grotta J. C., Malkoff M., Alexandrov A. V. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study. Stroke 2003; 34: 365–8